PAR
Click for more information
0.00% 30.0¢ paradigm biopharmaceuticals limited..

PAR -v- CUV, page-55

  1. Sojourner
    6,512 Posts.
    lightbulb Created with Sketch. 1912
    clock Created with Sketch.
    24/06/19
    13:11
    Post #: 39207112
    That seems more like a very modest price than an outrageous price to me.

    Eli Lilly/ Pfizer deal for Tanezumab was $1.8bn USD which was also only past phase 2 trials... and subsequently failed phase 3 due to the side effects.

    Let's use that as a base case for fair value and work upwards from there.
    Last edited by Sojourner: 24/06/19
    PAR Price at posting: $1.35 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RIO Rio registers 2% drop in iron ore production in 2nd quarter of 2024
right-arrow Created with Sketch.
BHP BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning
right-arrow Created with Sketch.
IVR Investigator Resources hits 8m @ 1.06% copper on-site Stuart Shelf JV project acreage
right-arrow Created with Sketch.
NEWS Almonty locks in govt agreement for tungsten oxide plant in South Korea
right-arrow Created with Sketch.
MEU Marmota hopes to punch through the ceiling of a high-grade system at Goolagong – geology willing
right-arrow Created with Sketch.
ENR Encounter sniffs 4% niobium across 1.6km of strike in WA
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $104.9M
Open High Low Value Volume
30.0¢ 31.0¢ 29.5¢ $89.62K 294.9K

Buyers (Bids)

No. Vol. Price($)
3 20607 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 16773 1
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.